As far as the semiquantitative scoring was concerned, among the 211 CD13-positive meningiomas, 27% of the tumors (56/211) showed weak (score 1) and 73% (155/211) strong (score 2) staining respectively. The gene discussed is ANPEP; the disease is meningioma.